COMMUNIQUÉS West-GlobeNewswire

Présentation de Merus lors de la conférence Wedbush PacGrow Healthcare 2018
07/08/2018
UTRECHT, Pays-Bas, 07 août 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), société d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics®), a [...]
XOMA Reports Second Quarter 2018 Financial Results
07/08/2018
EMERYVILLE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced its second quarter 2018 financial [...]
Checkpoint Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
07/08/2018
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Eidos Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
07/08/2018
SAN FRANCISCO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by [...]
Denali Therapeutics Appoints Dana Andersen, Ph.D., as Chief Technical and Manufacturing Officer
07/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, [...]
Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update
07/08/2018
--Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow CORAL GABLES, Fla., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing [...]
Aptose Reports Results for the Second Quarter Ended June 30, 2018
07/08/2018
Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing [...]
Aileron Therapeutics Reports Second Quarter 2018 Financial Results
07/08/2018
Preclinical in-vivo ALRN-6924 combination data with CDK4/6 inhibitors, PD-1/-L1 inhibitors, or paclitaxel (formulated as Abraxane or Taxol) all show promise in breast cancer and other cancer models Initiation of [...]
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
07/08/2018
MENLO PARK, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (Nasdaq:VSAR) today announced financial results for the second quarter ended June 30, 2018 and provided a review of recent corporate activities. “We [...]
Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue
07/08/2018
Total revenue of $99.5 million, a 31% increase over 2017 Net product sales of $97.0 million, a 32% increase over 2017 Operating earnings of $35.7 million, a 37% increase over 2017 Diluted earnings per share (GAAP) of $0 [...]
Calithera Biosciences Reports Second Quarter 2018 Financial Results and Recent Highlights
07/08/2018
- Two Novel Programs Entering Clinical Development -Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Calithera [...]
Alder BioPharmaceuticals® Reports Second Quarter 2018 Financial and Operating Results
07/08/2018
- Presented new eptinezumab Phase 3 clinical trial data in episodic and chronic migraine demonstrating robust efficacy that is sustained and further improved after repeat quarterly treatments - - Biologics License [...]
Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights
07/08/2018
Clinical data updates and regulatory feedback for VY-AADC during the quarter support planned pivotal program for Parkinson’s disease Pipeline programs progressing with updated preclinical data from ALS and Huntington’s [...]
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
07/08/2018
Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular [...]
Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
07/08/2018
Net loss was $59.9 million in the second quarter and $108.6 million for the first six months ended June 30, 2018 Net cash from operating and investing activities was $58.0 million in the second quarter and $26.3 million [...]
GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
SOUTH SAN FRANCISCO, Calif. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York City [...]
Athersys Reports Second Quarter 2018 Results
07/08/2018
Management to host conference call at 4:30pm EDT today CLEVELAND, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2018. [...]
miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
07/08/2018
Cobomarsen expansion indication data released; first observations from the ongoing Phase 1 clinical trial on safety and efficacy of cobomarsen in ATLL patients, additional data expected by year end New cobomarsen Phase [...]

Pages